13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients

Update Il y a 4 ans
Reference: NCT02492438

Woman and Man

  • | Country :
  • Belgium
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the immunogenicity of the PCV13 (13 valent pneumococcal conjugated vaccine) vaccine as compared to the PPV23 (23 valent pneumococcal polysaccharide vaccine) vaccine in patients treated with chronic hemodialysis that are pre-immunized with the PPSV23 vaccine or are PPV23 vaccine naïve by measuring the ELISA and OPA (opsonophagocytic assay) titers after 4 and 52 weeks.


Inclusion criteria

  • Chronic Kidney Failure

Links